Pramodini Medicare Limited is an India-based diagnostic service provider offering technology-enabled services across radiology, clinical laboratory, and nuclear medicine. The company serves public and private hospitals, medical colleges, PSUs, and diagnostic centres across Tier I, II, and III cities in India.
The company offers a wide range of diagnostic services, including MRI, CT Scan, X-ray, Ultrasound, Mammography, DEXA Scan, PET-CT, SPECT, pathology, and laboratory testing. It also operates a 24×7 teleradiology unit and a central processing laboratory in Vijayawada.
Service Model:
- Public-Private Partnership (PPP): Operates diagnostic centres within government hospitals and government teaching hospitals under long-term Memorandums of Understanding (MOUs).
- Private-Private Partnership (Pvt-Pvt): Establishes and manages diagnostic centres within private hospitals through partnership agreements.
- Strategic Partnerships with PSUs: Collaborates with Government of India Public Sector Undertakings (PSUs) to provide diagnostic and imaging services.
- Private Centres (Standalone Centres): Operates standalone diagnostic centres and laboratories serving both individual patients and institutional clients.
The company operates diagnostic centres through partnerships with hospitals, providing advanced diagnostic equipment, technology, and operational expertise. Services at each centre vary based on the respective agreement.
As of August 4, 2026, the company operated 16 diagnostic centres across 14 cities in seven Indian states, along with a processing laboratory in Vijayawada, and continues to expand its network by investing in advanced diagnostic infrastructure.
As of March 31, 2026, the company had 161 permanent employees supporting its operations across diagnostic centres and laboratories.
Pramodini Medicare IPO – Details
| IPO Opening Date | 12 August 2026 |
| IPO Closing Date | 14 August 2026 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue: 58,51,200 Shares Worth ₹69.04 Crore Fresh Issue: 53,50,800 Shares Worth ₹63.14 Crore Offer For Sale: 5,00,400 Shares Worth ₹5.90 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹110 – ₹118 per share |
| Market Lot | 1200 Shares |
| Min Order | 1200 Shares [ 1 Lot ] |
| Listing At | NSE SME |
| Registrar | Purva Sharegistry (India) Pvt. Ltd. |
| QIB Shares Offered | 45.91% |
| NII Shares Offered | 17.41% |
| Retail Shares Offered | 36.68% |
Pramodini Medicare IPO – Date Schedule
| IPO Open Date | 12 August 2026 |
| IPO Close Date | 14 August 2026 |
| Basis of Allotment | 17 August 2026 |
| Initiation of Refund | 18 August 2026 |
| Credit of Shares to Demat | 18 August 2026 |
| IPO Listing Date | 19 August 2026 |
| Cut-off time for UPI mandate confirmation | 5 PM on August 14, 2026 |
Pramodini Medicare IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2400 | ₹2,83,200 |
| Retail (Max) | 2 | 2400 | ₹2,83,200 |
| S-HNI (Min) | 3 | 3600 | ₹4,24,800 |
| S-HNI (Max) | 7 | 8400 | ₹9,91,200 |
| B-HNI (Min) | 8 | 9600 | ₹11,32,800 |
Competitive Strength
- Establishing a strategic presence across various states of India.
- Strengthening its network through diversified business models.
- Strong technical capabilities supported by robust IT infrastructure.
- Experienced management team with significant industry expertise.
- Consistent track record of revenue growth and financial performance.
- Diverse customer base, including hospitals, institutions, and individual patients.
Company Promoters
- Chalasani Durga Aashritha
- Chalasani Kavitha
- Chalasani Kuldeep Kumar
- Chalasani Lalithakumar
- Sri Ram Medicare Pvt. Ltd.
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2024 | ₹35.79 Cr | ₹25.72 Cr | ₹7.14 Cr | ₹11.96 Cr |
| 31 March 2025 | ₹38.55 Cr | ₹22.80 Cr | ₹11.14 Cr | ₹10.81 Cr |
| 31 March 2026 | ₹63.38 Cr | ₹40.08 Cr | ₹17.38 Cr | ₹17.85 Cr |
Key Performance Indicator
| KPI | Values (Mar 31, 2026) |
|---|---|
| ROE | 39.08% |
| ROCE | 34.66% |
| Debt/Equity | 0.34 |
| RoNW | 32.69% |
| PAT Margin | 27.90% |
| EBITDA Margin | 49.61% |
| NAV | 31.84 |
| Price to Book Value | 3.71 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 10.41 | 7.88 |
| P/E (x) | 11.34 | 14.97 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Funding of capital expenditure for the purchase of medical equipment towards Existing and Proposed Diagnostic Centres. | ₹45.15 |
| General corporate purposes and unidentified inorganic acquisition. | – |
✅Strengths
- Strategic presence across multiple states in India.
- Diversified business model across PPP, private hospitals, PSUs, and standalone centres.
- Strong technical capabilities supported by robust IT infrastructure.
- Experienced management team with significant industry expertise.
- Consistent track record of revenue growth and financial performance.
⚠️Risks
- High dependence on government contracts for a significant share of revenue.
- Loss of key customers or pricing pressure could impact profitability.
- Failure to maintain diagnostic quality standards could result in litigation and reputational damage.
- Expansion plans require significant capital expenditure and successful execution.
- Business operations depend on renewal and continuity of location-specific MoUs and partnership agreements.
Pramodini Medicare IPO Promoter Holding
| Pre-Issue Share Holding | 85.71% |
| Post Issue Share Holding | 62.64% |
Pramodini Medicare IPO Prospectus
- Pramodini Medicare IPO DRHP
- Pramodini Medicare IPO RHP
Company Contact Information
| Pramodini Medicare Limited D. No: 29-4-54K, CSI Complex, Prakasam Road, Suryaraopet, Vijayawada, Andhra Pradesh, 520002 Phone: +91 9985782727 Email: investors@pramodinidiagnostics.com Website: https://www.pramodinidiagnostics.com/ |
Pramodini Medicare IPO Registrar
| Purva Sharegistry (India) Pvt. Ltd. Phone: 022-41343255 Email: newissue@purvashare.com Website: https://www.purvashare.com/investor-service/ipo-query |
Pramodini Medicare IPO Lead Manager(s)
| 1. Smart Horizon Capital Advisors Private Limited |
Pramodini Medicare IPO FAQ
| What is the Pramodini Medicare IPO? Pramodini Medicare IPO is an SME IPO. The issue is priced at ₹110 – ₹118 per equity share. The IPO is to be listed on NSE SME. |
| When will Pramodini Medicare IPO open? The IPO is to open on 12 August 2026 for QIB, NII, and Retail Investors. |
| What is Pramodini Medicare IPO Investors’ Portion? The investors’ portion for QIB – 45.91%, NII – 17.41%, and Retail – 36.68%. |
| What is the Pramodini Medicare IPO Size? Pramodini Medicare IPO size is ₹69.04 Crore. |
| What are the Pramodini Medicare IPO Minimum and Maximum Lot Sizes for Retail Investors? The minimum bid is 2400 Shares for ₹2,83,200, while the maximum bid is 2400 Shares for ₹2,83,200. |
| What is the Pramodini Medicare IPO Allotment Date? Pramodini Medicare IPO allotment date is 17 August 2026. |
| What is the Pramodini Medicare IPO Listing Date? Pramodini Medicare IPO listing date is 19 August 2026. The IPO is to be listed on the NSE SME. |
